These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36849041)
1. Selective laser sintering additive manufacturing of dosage forms: Effect of powder formulation and process parameters on the physical properties of printed tablets. Tikhomirov E; Åhlén M; Di Gallo N; Strømme M; Kipping T; Quodbach J; Lindh J Int J Pharm; 2023 Mar; 635():122780. PubMed ID: 36849041 [TBL] [Abstract][Full Text] [Related]
2. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties. Thakkar R; Zhang Y; Zhang J; Maniruzzaman M Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262 [TBL] [Abstract][Full Text] [Related]
3. Powder bed fusion-laser beam (PBF-LB) three-dimensional (3D) printing: Influence of laser hatching distance on the properties of zolpidem tartrate tablets. Adamov I; Stanojević G; Pavlović SM; Medarević D; Ivković B; Kočović D; Ibrić S Int J Pharm; 2024 May; 657():124161. PubMed ID: 38677394 [TBL] [Abstract][Full Text] [Related]
4. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028 [TBL] [Abstract][Full Text] [Related]
5. Selective Laser Sintering of a Photosensitive Drug: Impact of Processing and Formulation Parameters on Degradation, Solid State, and Quality of 3D-Printed Dosage Forms. Thakkar R; Davis DA; Williams RO; Maniruzzaman M Mol Pharm; 2021 Oct; 18(10):3894-3908. PubMed ID: 34529431 [TBL] [Abstract][Full Text] [Related]
6. Investigating the Use of Magnetic Nanoparticles As Alternative Sintering Agents in Selective Laser Sintering (SLS) 3D Printing of Oral Tablets. Zhang Y; Thakkar R; Zhang J; Lu A; Duggal I; Pillai A; Wang J; Aghda NH; Maniruzzaman M ACS Biomater Sci Eng; 2023 Jun; 9(6):2924-2936. PubMed ID: 36744796 [TBL] [Abstract][Full Text] [Related]
7. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing? Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815 [TBL] [Abstract][Full Text] [Related]
8. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
9. Selective Laser Sintering 3-Dimensional Printing as a Single Step Process to Prepare Amorphous Solid Dispersion Dosage Forms for Improved Solubility and Dissolution Rate. Davis DA; Thakkar R; Su Y; Williams RO; Maniruzzaman M J Pharm Sci; 2021 Apr; 110(4):1432-1443. PubMed ID: 33227241 [TBL] [Abstract][Full Text] [Related]
10. Selective laser sintering (SLS) 3D printing of medicines. Fina F; Goyanes A; Gaisford S; Basit AW Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582 [TBL] [Abstract][Full Text] [Related]
11. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles. Enke M; Schwarz N; Gruschwitz F; Winkler D; Hanf F; Jescheck L; Seyferth S; Fischer D; Schneeberger A Int J Pharm; 2023 Jul; 642():123101. PubMed ID: 37295568 [TBL] [Abstract][Full Text] [Related]
12. 3D printing of drug-loaded gyroid lattices using selective laser sintering. Fina F; Goyanes A; Madla CM; Awad A; Trenfield SJ; Kuek JM; Patel P; Gaisford S; Basit AW Int J Pharm; 2018 Aug; 547(1-2):44-52. PubMed ID: 29787894 [TBL] [Abstract][Full Text] [Related]
13. Oral preparations with tunable dissolution behavior based on selective laser sintering technique. Yang Y; Xu Y; Wei S; Shan W Int J Pharm; 2021 Jan; 593():120127. PubMed ID: 33253801 [TBL] [Abstract][Full Text] [Related]
14. Impact of polymer chemistry on critical quality attributes of selective laser sintering 3D printed solid oral dosage forms. Evgenii T; Valerie L; Michelle Å; Nicole DG; Maria S; Thomas K; Julian Q; Jonas L Int J Pharm X; 2023 Dec; 6():100203. PubMed ID: 37564113 [TBL] [Abstract][Full Text] [Related]
15. Poly(vinyl alcohol) 3D printed tablets: The effect of polymer particle size on drug loading and process efficiency. Saviano M; Aquino RP; Del Gaudio P; Sansone F; Russo P Int J Pharm; 2019 Apr; 561():1-8. PubMed ID: 30817983 [TBL] [Abstract][Full Text] [Related]
16. Preparation of oral solid dosage forms based on homogenized spot melting technique. Wei S; Shen L; Xu X; Shan W; Yang Y Int J Pharm; 2022 Jul; 623():121928. PubMed ID: 35718250 [TBL] [Abstract][Full Text] [Related]
17. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data. Seoane-Viaño I; Pérez-Ramos T; Liu J; Januskaite P; Guerra-Baamonde E; González-Ramírez J; Vázquez-Caruncho M; Basit AW; Goyanes A J Control Release; 2024 Jan; 365():348-357. PubMed ID: 37972762 [TBL] [Abstract][Full Text] [Related]
18. Smart laser Sintering: Deep Learning-Powered powder bed fusion 3D printing in precision medicine. Abdalla Y; Ferianc M; Awad A; Kim J; Elbadawi M; Basit AW; Orlu M; Rodrigues M Int J Pharm; 2024 Aug; 661():124440. PubMed ID: 38972521 [TBL] [Abstract][Full Text] [Related]
19. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613 [TBL] [Abstract][Full Text] [Related]
20. Computer numerical control (CNC) carving as an on-demand point-of-care manufacturing of solid dosage form: A digital alternative method for 3D printing. Kaba K; Purnell B; Liu Y; Royall PG; Alhnan MA Int J Pharm; 2023 Oct; 645():123390. PubMed ID: 37683980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]